tiprankstipranks
Trending News
More News >
Kangji Medical Holdings Limited (HK:9997)
:9997
Hong Kong Market

Kangji Medical Holdings Limited (9997) Ratios

Compare
3 Followers

Kangji Medical Holdings Limited Ratios

HK:9997's free cash flow for Q4 2024 was ¥0.79. For the 2024 fiscal year, HK:9997's free cash flow was decreased by ¥ and operating cash flow was ¥0.56. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
7.92 17.72 20.33 27.18 38.84
Quick Ratio
7.50 17.16 19.64 26.59 38.15
Cash Ratio
4.32 14.03 18.34 25.34 29.58
Solvency Ratio
2.10 1.64 1.88 3.61 3.09
Operating Cash Flow Ratio
2.15 2.20 2.08 3.74 2.93
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
¥ 1.77B¥ 3.06B¥ 2.86B¥ 3.04B¥ 2.85B
Leverage Ratios
Debt-to-Assets Ratio
<0.01 0.01 0.01 <0.01 <0.01
Debt-to-Equity Ratio
<0.01 0.01 0.01 <0.01 <0.01
Debt-to-Capital Ratio
<0.01 0.01 0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.11 1.17 1.18 1.04 1.03
Debt Service Coverage Ratio
0.00 145.37 258.50 1.78K 6.39K
Interest Coverage Ratio
0.00 196.04 237.88 2.13K 7.42K
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
<0.01 0.04 0.04 <0.01 <0.01
Net Debt to EBITDA
-2.00 -5.67 -4.72 -6.90 -6.98
Profitability Margins
Gross Profit Margin
79.08%80.04%80.78%81.55%84.36%
EBIT Margin
53.57%47.78%71.85%60.52%60.93%
EBITDA Margin
55.78%50.17%74.60%61.90%62.39%
Operating Profit Margin
58.76%47.78%56.72%60.52%60.93%
Pretax Profit Margin
67.90%63.58%71.61%77.43%60.62%
Net Profit Margin
57.65%54.43%60.88%66.18%48.93%
Continuous Operations Profit Margin
56.64%48.84%58.65%66.18%50.67%
Net Income Per EBT
84.90%85.61%85.01%85.46%80.72%
EBT Per EBIT
115.55%133.06%126.26%127.95%99.49%
Return on Assets (ROA)
19.92%11.82%12.01%13.47%8.29%
Return on Equity (ROE)
22.12%13.81%14.19%14.01%8.52%
Return on Capital Employed (ROCE)
22.30%10.86%11.64%12.76%10.58%
Return on Invested Capital (ROIC)
18.58%8.33%9.53%10.91%8.86%
Return on Tangible Assets
19.92%13.22%13.55%13.47%8.29%
Earnings Yield
8.40%6.86%5.54%5.77%2.08%
Efficiency Ratios
Receivables Turnover
3.71 4.11 4.82 8.51 5.85
Payables Turnover
5.13 5.41 7.28 6.97 7.01
Inventory Turnover
1.95 1.76 1.43 1.86 1.56
Fixed Asset Turnover
3.66 3.24 2.93 6.43 6.03
Asset Turnover
0.35 0.22 0.20 0.20 0.17
Working Capital Turnover Ratio
0.40 0.30 0.26 0.23 0.31
Cash Conversion Cycle
214.47 229.23 280.17 186.54 244.99
Days of Sales Outstanding
98.41 88.90 75.73 42.89 62.37
Days of Inventory Outstanding
187.24 207.76 254.57 195.99 234.65
Days of Payables Outstanding
71.18 67.43 50.12 52.34 52.03
Operating Cycle
285.65 296.66 330.30 238.89 297.02
Cash Flow Ratios
Operating Cash Flow Per Share
0.48 0.36 0.26 0.36 0.23
Free Cash Flow Per Share
0.43 0.28 0.20 0.33 0.21
CapEx Per Share
0.05 0.07 0.06 0.03 0.02
Free Cash Flow to Operating Cash Flow
0.90 0.79 0.76 0.93 0.92
Dividend Paid and CapEx Coverage Ratio
0.33 1.38 1.25 5.76 0.96
Capital Expenditure Coverage Ratio
10.08 4.77 4.22 14.12 12.40
Operating Cash Flow Coverage Ratio
159.35 9.54 6.51 107.70 43.77
Operating Cash Flow to Sales Ratio
0.56 0.45 0.41 0.63 0.43
Free Cash Flow Yield
7.29%4.51%2.82%5.11%1.69%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
11.91 14.59 18.05 17.33 48.10
Price-to-Sales (P/S) Ratio
6.86 7.94 10.99 11.47 23.54
Price-to-Book (P/B) Ratio
2.63 2.01 2.56 2.43 4.10
Price-to-Free Cash Flow (P/FCF) Ratio
13.72 22.16 35.47 19.55 59.25
Price-to-Operating Cash Flow Ratio
12.36 17.52 27.06 18.17 54.47
Price-to-Earnings Growth (PEG) Ratio
0.85 1.94 2.23 0.41 1.60
Price-to-Fair Value
2.63 2.01 2.56 2.43 4.10
Enterprise Value Multiple
10.31 10.16 10.01 11.63 30.75
Enterprise Value
EV to EBITDA
10.31 10.16 10.01 11.63 30.75
EV to Sales
5.75 5.10 7.47 7.20 19.18
EV to Free Cash Flow
11.50 14.23 24.10 12.27 48.29
EV to Operating Cash Flow
10.36 11.25 18.39 11.40 44.39
Tangible Book Value Per Share
2.24 2.98 2.70 2.66 3.08
Shareholders’ Equity Per Share
2.24 3.11 2.79 2.66 3.08
Tax and Other Ratios
Effective Tax Rate
0.17 0.23 0.18 0.15 0.16
Revenue Per Share
0.86 0.79 0.65 0.56 0.54
Net Income Per Share
0.49 0.43 0.40 0.37 0.26
Tax Burden
0.85 0.86 0.85 0.85 0.81
Interest Burden
1.27 1.33 1.00 1.28 0.99
Research & Development to Revenue
0.08 0.14 0.08 0.05 0.05
SG&A to Revenue
0.10 0.11 0.09 0.09 0.09
Stock-Based Compensation to Revenue
<0.01 <0.01 0.01 0.01 0.04
Income Quality
0.96 0.71 0.67 0.95 0.88
Currency in CNY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis